A common antibiotic may be as
effective as oestrogen in preventing
devastating bone loss caused by
osteoporosis, suggests a new study
conducted in the US. Minocycline, a
derivative of tetracycline, not only
appears to forestall bone loss but
also develop bone density. The
study, by C T Liang of the National
Institute of Aging in Baltimore, conducted on rats, has immediately
prompted the National Institutes
of Health, Bethesda, to support a
clinical trial on humans (Nature
Medicine@ Vol 3, No 3).